chartexchange

Isomorphic Labs and MSD Enter Strategic Research Collaboration

PR Newswire | Nov 19, 2026 6:45 AM EST

LONDON, Nov. 19, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, and MSD, trade name of Merck & Co., Inc., Rahway, NJ, USA, today announced a research collaboration that brings together Isomorphic Labs' AI approach to drug discovery with MSD's rich...

Read original article